XML 18 R33.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Expense And Related Tax Benefit For Equity-Based Payments
                 
     Three Months Ended  
     March 31, 2012      April 2, 2011  

Cost of sales

   $ 235       $ 233   

Selling and marketing

     361         273   

Research and development

     388         319   

General and administrative

     2,816         2,188   
    

 

 

    

 

 

 

Total compensation

   $ 3,800       $ 3,013   
    

 

 

    

 

 

 

Income tax benefit

   $ 1,021       $ 1,046   
    

 

 

    

 

 

 
Weighted-Average Assumptions Used For Grants Of Stock Options And SARs
         
     Three Months Ended
     March 31, 2012    April 2, 2011

Expected dividend yield

   0%    0%

Forfeiture rate

   11.50%    9.78%

Volatility

   35.33%    39.50%

Risk free interest rate

   2.01%    2.26%

- Range of interest rates

   0.01% - 3.18%    0.06% - 3.41%

Expected weighted-average life

   5.42 years    5.36 years

Fair value of options and SARs granted

$   0 132,000

Weighted-average grant date fair value of options and SARs granted

$   0 14.40
Summary Of SAR Activity
                 
     Three Months Ended March 31, 2012  

SARs

  
Shares
    Weighted-Average
Exercise Price
 

Outstanding at beginning of year

     1,287,724      $ 28.91   

Granted

     0        0.00   

Exercised

     (17,343     24.49   

Forfeited

     (10,665     34.45   
    

 

 

   

 

 

 

Outstanding at end of period

     1,259,716      $ 28.93   
    

 

 

   

 

 

 

Exercisable at end of period

     293,246      $ 23.37   
    

 

 

   

 

 

 

Intrinsic value of exercised SARs

   $ 269,978           
    

 

 

         
Summary Of Outstanding And Exercisable Options
                                         
    Outstanding      Exercisable  

Range of Exercise Prices

   Number
of Shares
     Weighted-Average
Remaining
Contractual Life
     Weighted-Average
Exercise Price
     Number
of Shares
     Weighted-Average
Exercise Price
 

$   1.29-$36.49

     477,658         4.91 years       $ 32.25         382,829       $ 31.67   

$ 36.80-$41.25

     384,646         5.06 years         39.80         377,221         39.85   

$ 42.28-$45.62

     401,316         3.49 years         44.51         401,316         44.51   

$ 46.18-$51.62

     374,856         2.70 years         48.63         374,856         48.63   

$ 53.92-$53.92

     1,800         2.16 years         53.92         1,800         53.92   
    

 

 

                      

 

 

          
       1,640,276                           1,538,022            
    

 

 

                      

 

 

          

 

                 
     Outstanding      Exercisable  

Aggregate intrinsic value

   $ 3,160,000       $ 2,785,000   

Weighted-average remaining contractual term

     4.1 years         4.0 years   

 

Summary Of Stock Option Activity
                 
     Three Months Ended March 31, 2012  

Options

  
Shares
    Weighted-Average
Exercise Price
 

Outstanding at beginning of year

     1,702,650      $ 40.43   

Granted

     0        0.00   

Exercised

     (48,561     26.94   

Forfeited

     (1,663     36.36   

Expired

     (12,150     45.93   
    

 

 

   

 

 

 

Outstanding at end of period

     1,640,276      $ 40.79   
    

 

 

   

 

 

 

Exercisable at end of period

     1,538,022      $ 41.18   
    

 

 

   

 

 

 

Intrinsic value of exercised options

   $ 545,701           
    

 

 

         
Summary Of Restricted Stock Award Activity
                 
     Three Months Ended March 31, 2012  

Restricted Stock Awards

  
Shares
    Weighted-Average
Grant Date Fair Value
 

Outstanding at beginning of year

     836,141      $ 28.34   

Granted

     2,948        39.01   

Released

     0        0.00   

Forfeited

     (5,155     32.58   
    

 

 

   

 

 

 

Outstanding at end of period

     833,934      $ 28.35   
    

 

 

   

 

 

 
Summary Of Awards Granted Under Equity-Based Compensation Plans
         
     As of  
     March 31, 2012  

Awards granted under Zebra's equity based compensation plans:

        

Unearned compensation costs related to awards granted

   $ 16,622,000   

Period expected to be recognized over

     2.2 years   
Weighted-Average Assumptions Used For Employee Purchase Rights Granted Under Stock Purchase Plan
                 
     Three Months Ended  
     March 31, 2012     April 2, 2011  

Fair market value

   $ 35.78      $ 37.99   

Option price

   $ 33.99      $ 36.09   

Expected dividend yield

     0     0

Expected volatility

     20     26

Risk free interest rate

     0.02     0.12
Stock Appreciation Rights (SARs) [Member]
 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary Of Outstanding And Exercisable Options
                                         
    Outstanding      Exercisable  

Range of

Exercise Prices

   Number
of Shares
     Weighted-Average
Remaining
Contractual Life
     Weighted-Average
Exercise Price
     Number
of Shares
     Weighted-Average
Exercise Price
 

$ 19.56-$19.56

     403,506         7.10 years       $ 19.56         172,175       $ 19.56   

$ 21.83-$27.50

     57,014         7.60 years         24.83         39,203         24.51   

$ 27.82-$27.82

     420,872         8.10 years         27.82         62,687         27.82   

$ 28.33-$40.10

     33,483         8.84 years         32.08         3,136         32.26   

$ 41.57-$42.36

     344,841         9.10 years         41.61         16,045         42.36   
    

 

 

                      

 

 

          
       1,259,716                           293,246            
    

 

 

                      

 

 

          

 

                 
     Outstanding      Exercisable  

Aggregate intrinsic value

   $ 13,133,000       $ 4,498,000   

Weighted-average remaining contractual term

     8.1 years         7.5 years